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The following studies were undertaken with the purpose of throw- 
ing more light, if possible, on the influence exerted by immune serum 
on  the  metabolic  activities  of  bacteria.  It  has  been  shown  that 
under  certain  experimental  conditions  immune  serum  possesses  the 
property of inhibiting or markedly retarding the metabolic functions 
of various microorganisms.  Bacterial metabolic processes are gener- 
ally considered to be enzymotic in nature.  It is not known whether 
they take place primarily at the surface of the bacterial cell or within 
the  cell body.  It is probable,  however, that  exogenous metabolism 
occurs  to  a  considerable  extent  in  preparing  nutrient  material  for 
absorption. 
Evidence for this may be found in the studies  by Cole  1 on the formation of 
methemoglobin by the pneumococcus.  The property of immune serum which 
enables it to inhibit the metabolic activities of bacteria is considered to act at the 
surface of the bacterial cell and to be antienzymotic in nature.  The term anti- 
blastic immunity has been applied as descriptive of the phenomenon. 
Yon Dungern  2 has shown  that  the liquefaction of gelatin by Staphylococcus 
pyogenes aureus is inhibited by antistaphylococcus  immune serum; Gh~orghiewsky  z 
showed  that immune serum inhibits pigment formation by B. pyocyaneus; and 
Ascoli  4 considered  that the action of antianthrax serum was in part dependent 
upon the inhibition of  capsule  formation by B. anthracis with consequent sup- 
pression  of  the  metabolic  activities of  the  organism.  More  recently Dochez 
and Avery  z have shown that antipneumococcus  immune serum retards the growth 
of the pneumococcus  and inhibits or markedly delays the fermentation of inulin 
and the splitting of protein by the pneumococcus. 
* This work was  done under the tenure of a  William  O. Moseley Travelling 
Fellowship  from Harvard University. 
1 Cole, R., J. Exp. Med.,  1914, xx, 363. 
~von Dungern, Centr. Bakteriol., 1re Abt.,  1898, xxiv, 710. 
3 Gh6orghiewsky, Ann. Inst. Pasteur, 1899, xiii, 298. 
4 Ascoli, A., Centr. Bakteriol., lte Abt., Orig., 1908, xlvi, 178. 
5  Dochez, A. R., and Avery, O. T., J. Exp. Med., 1916, xxiii, 61. 
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EXPERIMENTAL. 
The  majority  of  the  experiments  reported  below  deal  with  the 
antiblastic  properties  of  antipneumococcus  serum.  A  few  experi- 
ments have been done with antistaphylococcus serum. 
Inhibition of the Metabolic Activities of the Pneumococcus by Anti- 
pneumococcus Immune Serum. 
Characteristic  metabolic  functions  of  the  pneumococcus  are  the 
fermentation  of inulin  and litmus milk,  the splitting  of protein,  and 
the  transformation  of  oxyhemoglobin  to  methemoglobin.  The  in- 
fluence  which  immune  serum  exerts on these functions of the pneu- 
mococcus has been studied.  The experiments of Dochez and Avery 
have  been  repeated  and  extended  and  their  experimental  results 
confirmed in  that  under  certain  conditions  antipneumococcus  serum 
has been found to possess the property of inhibiting or retarding  the 
metabolic  activities  o'f pneumococci.  The  conclusions  drawn  from 
our experiments  as  to the mechanism  of this  inhibitory  property  of 
anfipneumococcus serum,  however, differ from those of Dochez and 
Avery. 
Experiment 1.  Inhibition  of  the  Growth of the Pneumococcus by Antipneumo- 
coccus Serum.--In Table I  is shown one of a series of experiments on the rate 
of growth of the pneumococcus  in homologous  and heterologous antipneumococcus 
serum and in normal horse serum.  The  amount  of growth was determined by 
the plate method. 
This  experiment  shows  that  an  apparent  inhibition  of  growth 
occurs  in  homologous  antipneumococcus  serum  as  compared  with 
that in normal  serum during  a  period of 3 hours,  that  a  retardation 
of growth occurs up to 6  hours,  but that  by 24 hours an abundant 
growth is present in the immune serum as well as in the normal serum. 
It  furthermore  appears  that  there is some retardation  of growth  of 
Type  I  pneumococcus  by  the  heterologous  immune  serum,  a  phe- 
nomenon  which  doe~ not occur with  Type II pneumococcus.  These 
results  agree with  those of Dochez and  Avery.  It is felt, however, 
that the interpretation  of such results as indicative of actual retarda- 
tion of growth is open to serious objection.  It is clear that  the ap- 
parent inhibition  of growth by homologous serum must in large part ~'RANCIS  O.  BLAKE  565 
TABLE  I. 
Inhibition of the Growth of the Pneumococcus by Antipneumococcus Serum. 
Culture 0.00000001  cc. 
Pneumococcus Type  I 
PneumococcusType II[ 
"  "  II 
,,  ,4  II 
Serum 0.2  co. 
Antipneumococcus  Se- 
rum Type  I 
Antipneumococcus  Se- 
rum Type II 
Normal horse serum. 
Antipneumococcus  Se- 
rum Type I 
Antipneumococcus  Se- 
rum Type II 
Normal horse serum. 
Imme- 
diately. 
61 
5O 
37 
31 
43 
29 
No. of colonies. 
After 
3 hrs. 
54 
45 
284 
69 
42 
59 
After 
6 hrs. 
80 
12,000 
22,000 
6,200 
1,850 
7,750 
After 24 hrs. 
Confluent. 
Confluent. 
4¢ 
be due to agglutination.  Furthermore, it is well known that during 
the first hours of growth of the pneumococcus chain formation occurs 
to  a  considerable extent.  This is  a  variable phenomenon which is 
difficult to control.  For these reasons it seems hazardous to conclude 
from the experiments that immune serum actually retards the growth 
of the pneumococcus and quite as probable  that the inhibition indi- 
cated by the colony counts is more apparent than real. 
Experiment  2.  Inhibition  of "the Fermentation  of Inulin  and  Litmus  Milk  by 
Antitmeumococcus  Serum.--The  power  of  antipneumococcus  serum  to  inhibit 
the fermentation of inulin and litmus milk by the.pneumoeoccus has been tested 
in a  considerable series of experiments, one of which is shown in Table II. 
This experiment demonstrates that the fermentation of litmus milk 
by  the  pneumococcus is  markedly delayed in  the  presence  of  the 
homologous immune serum.  ,The fermentation of inulin is retarded 
by  antipneumococcus  serum  in  a  similar  manner.  In  the  tubes 
containing  the  homologous  immune  serum  the  organisms  grow  in 
agglutinated masses  at  the  bottom  of the tube,  while in  the  tubes 
containing  the  heterologous or  normal  serum  they  grow  diffusely. 
To demonstrate clearly inhibition of fermentation it was found neces- 
sary to  use  extremely small  amounts  of pneumococcus culture (not 
more than 0.00001  cc.)  in  inoculating the media.  With  the use of 566  ANTIBLASTIC  IMMIYNITY 
TABLE  II. 
Inhibition of the Fermentation of Litmus Milk by Antipneumococcus Serum. 
Culture 0.000001 cc. 
Pneumococcus Type I 
"  "  I 
Pneumococcus Type II 
"  "  II 
"  "  II 
Litmus milk 4 cc. + 
Serum l  cc. 
Antipneumococcus Serum Type  I 
"  "  "  II 
Normal horse serum. 
Antipneumococcus Serum Type  I 
"  "  "  II 
Normal horse serum. 
Incubation at 37°C. 
24 
hrs. 
++ 
++ 
++ 
++ 
48  72  5 
hrs.  hrs.  :lays. 
--  + 
++ ++++ 
++ ++ ++ 
++ ++ ++ 
+_  ~-  + 
++ ++  ++ 
+ +  indicates complete acidification and coagulation;  +_+, acid and incomplete 
coagulation;  +,  acid and beginning  coagulation;  ±,  acid  and no coagulation; 
+  slight  acidification  and no coagulation;  -  no acidification  or coagulation. 
larger  amounts  retardation  of  fermentation  was  very slight  or  did 
not occur at all.  In a series of experiments to determine the maximum 
amount Of culture that could be used satisfactorily in demonstrating 
the antiblastic  action of immune  serum in preventing the fermenta- 
tion of inulin, it was frequently noted that in the immediate vicinity 
of the  agglutinated  pneumococci at  the  bottom of the  culture  tube 
there  was  acidification  of  the  medium  indicated  by  change  of  the 
litmus  indicator  to  red,  while  the  upper portion of the medium  re- 
mained  unchanged.  This  observation  suggested  the  possibility 
that the apparent antiblastic  action of antipneumococcus serum was 
in reality due merely to agglutination of the organisms at the bottom 
of the culture tube and their consequent inability to come into inti- 
mate contact with the medium as a  whole, this not being the case in 
the presence of heterologous immune or normal serum.  If this is so, 
to conclude from such experiments as those cited  above that immune 
serum possesses a specific antiblastic action would hardly be justified. 
Further experiments on this point are given below. 
Experiment  3.  Inhibition  of  Methemoglobin Formation  by  Antipneumococcus 
Serum.--The  transformation  of  oxyhemoglobin  to  methemoglobin is  a  char- 
acteristic metabolic function of the pneumococcus  which lends itself readily to 
in vitro experiments.  A large  series of experiments has been done in order to 
determine  under  what  conditions  antipneumococcus  serum  will  inhibit  this FRANCIS  G.  BLAKE  567 
activity of the pneumococcus.  In general, the results have been similar to those 
obtained in the case  of litmns milk and inulin.  To demonstrate inhibition, it 
was found essential to use very small amounts of pneumococci in inoculating the 
hemoglobin solution-serum mixtures and to  allow the  cultures to  incubate  24 
hours.  One of  these  experiments is  shown in Table III,  which  demonstrates 
that  under these  conditions homologous antipneumoeoccus serum inhibits the 
transformation  of  oxyhemoglobin  to  methemoglobin  by  the  pneumococcns. 
Heterologons immune serum and normal horse  serum possessed  no inhibitory 
properties. 
TABLE  HI. 
Inhibition  of Methemoglobin Formation by Antipneumococcus Serum. 
Hemoglobin solution* 1 cc. + 
Culture 0.00001  ce. 
Pneumococcus Type  I 
"  "  I 
"  "  I 
Pneumococcus q~cpe II 
"  "  II 
Serum l  co. 
Antipneumococcus Serum Type  I 
"  "  "  II 
Normal horse serum. 
Antipneumococcus Serum Type  I 
"  "  "  II 
Normal horse serum. 
After  After 
24hrs  48 hrs. 
++  ++ 
++  ++ 
++ 
-4- 
++  ++ 
+  +  indicates complete transformation of oxyhemoglobin to methemoglobin; 
"-, slight methemoglobin formation; -, no methemoglobin formation. 
* Hemoglobin solution  =  2  ce.  of  a 5  per cent suspension of washed rabbit 
corpuscles +  8 cc. of distilled water +  30 cc. of 0.85 per cent salt solution. 
With the use of larger amounts of culture it was found that the 
formation of methemoglohin was  not inhibited  by immune serum, 
but took place rapidly in the immediate vicinity of the agglutinated 
pneumococci and gradually diffused upward  throughout  the  whole 
medium.  These results,  as in  the case of inulin, suggested that the 
apparent  inhibition  which occurs when minute  amounts  of culture 
are used is due to inability of the agglutinated pneumococci to come 
into intimate contact with the medium as a whole. 
Experiment  4.  Inhibition  of  the  Proteolytic  Functions  of  the Pneumococcus  by 
Antipneumococcus Serum.--The  growth of pneumococcus in a serum broth medium 
is attended by an increase in the amino-acid content of the medium.  Doche~ 
and Avery  5 believe it probable that the pneumococcus effects  a  splitting of pro- 568  ANTIBLASTIC  IMMUNITY 
tein before absorption and that the increase in amino-acid content of the medium 
represents the excess of protein split over that used up in the process of growth. 
If this hypothesis is accepted, the increase in amino-acid produced by the growth 
of the pneumococcus might serve as a measure of the proteolytic activity of the 
pneumococcus  in  a  given  culture,  the  amount  of increase being directly pro- 
portional to the total amount split.  The possibility should be pointed out, how- 
ever, that the amount of amino-acid increase  might be inversely proportional to 
the metabolic activities of the pneumococcus,  a  small amino-acid increase  indi- 
cating a greater utilization of the total amount of protein split, and vice versa. 
The experiment recorded in Table IV shows the increase in amino-acid nitrogen 
when the pneumococcus was grown in broth containing antipneumococcus serum 
as  compared with  the  increase  in  the  presence  of  normal  horse  serum.  The 
increase in amino-acid was determined by the method of Van Slyke. 6 
TABLE  IV. 
Inhibition  of the Proteolytic Activities  of the Pneumococcus  by  Antipneumococcus 
Serum. 
Broth 8 cc. -4-  Increase in 
amino nitrogen 
per cc. after 
Culture 0.000002  ec.  Serum 2 cc.  48 hrs. at 37* C. 
trig. 
Pneumococcus Type I  Antipneurnococcus  Serum Type  I  0.031 
"  "  I  "  "  "  II  0.103 
"  "  I  Normal horse serum.  0. 106 
If the increase in amino nitrogen content of the medium is a  direct 
measure  of  the  proteolytic  activities  of the  pneumococcus,  it  is  ap- 
parent  that  the  homologous  antipneumococcus  serum  exerted  a 
marked  inhibitory  action  on  this  metabolic  function  of  the  pneu- 
mococcus.  Since  the  pneumococcus  growth  in  the  tube  containing 
homologous immune serum was in agglutinated masses at the bottom 
of  the  tube  in  contradistinction  to  the  diffuse  growth  in  the  other 
tubes,  it  seemed  possible  that  this  factor  might be  responsible  for 
the  apparent  inhibition  of proteolytic  activity rather  than  any true 
antienzymotic  property  of  the  serum.  A  further  experiment  to 
determine the influence of this factor is presented below. 
Experiment  5.  Antiblastic  Properties  of Exhausted  Immune  Serum.--A  series 
of experiments was done to determine whether immune serum exhausted of its 
~Van  Slyke, D. D., J. Biol.  Chem.,  1913-14,  xvi, 121; 1915, xxiii, 407. :FRANCIS  G.  BLAKE  569 
agglutinin  and  precipitin  content  by repeated  exposure to  killed  pneumococci 
still retained any demonstrable antiblastic properties.  In Table V is shown one 
of these experiments from which it will be seen that immun~ serum exhausted of 
its agglutinin and precipitin content possesses no power to inhibit the  formation 
of methemoglobin by the pneumococcus.  Identical results have been obtained 
with respect to the fermentation of inulin  and litmus milk.  From these experi- 
ments it is evident that the specific antiblastic action of immune serum, if such 
exists,  is removed from the  serum at  the same time that  the  agglutinins and 
precipitins are removed by treatment with dead pneumococcl. 
TABLE  V. 
Antiblastic Properties of Exhausted Antipneumococcus Serum. 
Hemoglobin solution 1 cc. + 
Culture 0.00001  co. 
Pneumococcus Type I 
Pneumococcus  Type II 
"  "  II 
Serum 1 ec. 
Anfipneumococcus  Serum Type I 
Exhausted  "  "  "  I 
Antipneumococcus  Serum Type II 
Exhausted  "  "  "  II 
Methemoglobin 
formation. 
After  After 
24 hrs.  48 hrs. 
m 
++  ++ 
-4- 
++  ++ 
Experiment  6. R~lation of  Agglutinins  to  Antiblast4e Immunity.--From  the 
results obtained in the foregoing  experiments the suggestion arose that the ap- 
parent  antiblastic action of antipneumococcns serum was in some way closely 
related to agglutination of the bacteria.  The following experiment was done to 
determine  more  accurately  this  relationship.  Equal  parts  of  pneumococcus 
cultures and increasing serum dilutions were mixed in small tubes and incubated 
for 2 hours at 37°C.  1 co. of hemoglobin solution was then carefully added to 
each tube so as not to disturb the agglutinated pneumococci and the tubes were 
incubated for 1 hour at 37°C,  The results are shown in Table VI. 
This  experiment  shows  that  the  anfiblastic  action  of  the  serum 
bears  a  definite  relationship  to  the  degree of  agglutination  of  the 
pneumococci.  In  the  tube  containing  the  1:25  serum  dilution  ag- 
glutination  was  complete,  the  pneumococci  having  entirely  settled 
to the bottom of the tube,  and complete inhibition ofmethemoglobin 
formation  occurred.  With  increasing  dilutions  of  serum  agglutina- 
tion and sedimentation were progressively less complete and formation 
of methemoglobin rapidly took place in the immediate neighborhood 
of the  agglutinated  pneumococci,  the  upper  portion  of  the  medium 570  ANTIBLASTIC IMMUNITY 
TABLE VI. 
Relation of Antiblastic Immunity to Agglutination. 
Culture  0.5 co. 
Pneumococcus  Type I 
~c  *c  I 
cc  ~  I 
~c  cc  I 
"  "  I 
Serum0.5  co. 
Antipneumococcus Serum Type 
I  (1: 25) 
A~atipneumococcus  Serum Type 
I (1: 50) 
Antipneumococcus Serum Type 
I (1: 100) 
Antipneumococcus Serum Type 
I (1: 200) 
Antipneumococcus Serum Type 
I  (1:4o0) 
Antipneumococcus  Serum Type 
II (1: 25) 
Normal horse serum (1: 25) 
• ~e~  . 
++ 
++ 
+ 
-4- 
1 cc. of hem- 
oglobin 
solution 
added to 
each tube. 
;~o 
m 
++ 
++ 
++ 
++ 
++ 
++ 
indicates  methemoglobin  formation in  the  immediate  vicinity  of  the 
agglutinated pneumococci, the upper portion of the medium remaining unchanged. 
from which the bacteria had settled out remaining unchanged.  This 
experiment  indicates  that  the  antiblasfic  property  of  antipneu- 
mococcus serum probably depends in  large measure,  if not entirely, 
upon its ability to agglutinate  the pneumococci and thereby prevent 
their coming into intimate contact with the medium as a  whole. 
By  growing  pneumococci  in  a  serum-hemoglobin  solution  agar 
medium, agglutination of the pneumococci may be prevented.  Under 
these  conditions  antipneumococcus  serum  was  found  not to inhibit 
methemoglobin  formation.  An  objection  may  be  raised  to  these 
experiments,  however,  because  it  is  not  certain  that  in  a  solid 
medium  the  immune  serum  is  in  sufficient concentration in  the im- 
mediate  vicinity of  the  pneumococcus  colonies  to  exert  a  demon- 
strable  anfiblasfic  action. 
Experiments 7 and 8.  Relation of Antiblastic Immunity to the Ability of Bacteria 
to Come into Inti~nate  Contact wltk the Medium.--It seemed probable from many 
of  the  previous  experiments  that  the  antiblastic action of antipneumococcus 
serum was due to inability of the agglutinated bacteria to come into sufficiently :FRANCIS G.  BLAKE  571 
intimate  contact with  the  medium as a  whole  to enable  them to  produce  the 
characteristic  changes  in  the  medium.  Under  these  conditions  the  metabolic 
activities  of the pneumococci could exert  their influence only in the immediate 
vicinity of the agglutinated  bacteria  and complete change  of the medium  could 
take place  only as gradual  diffusion occurred.  This  is exactly what did occur 
when moderately large  amounts of pneumococci were used,  the reaction  in the 
presence of homologous immune serum  being merely retarded rather than com- 
pletely  inhibited.  When  minute  amounts  of  pneumococci  were  used  growth 
had probably ceased before diffusion could take place and apparently complete 
inhibition  resulted. 
In order to obviate this difficulty, two sets'of experiments  have been carried 
out.  The first  consisted in running a parallel  series of tubes,  one of which was 
shaken,  the other not.  The second group of experiments  consisted in a parallel 
series of cultures, one in test-tubes,  the  other in small flasks so that the aggluti- 
nated bacteria  would be brought into much more intimate contact with the medium 
as a  whole, which was in a  thin  layer at the bottom of the flasks, than could 
possibly occur in test-tube cultures.  The effect of shaking is well demonstrated 
in the experiment  shown in Table VII. 
TABLE  VII. 
Effect  of Shaking on the Inhibition  of Methemoglobin Formation  by  Ant~pneumo- 
COCC~S S~u1~b, 
2  hrs. at 37°C. 
Culture 0.5 cc. 
Pneumococcus Type I 
"  "  I 
Serum 0.5 cc. 
Antipneumo- 
coccus  Serum 
Type I 
Antipneumo- 
coccus  Serum 
Type I 
icc. ofhem- 
oglobin so- 
luHon  in 
each tube. 
Incubation at 37°C. 
Unshaken. 
Shaken.  ++  ++ ++ 
++ 
Suitable  control  tubes  showed  that  normal  horse  serum  did  not 
inhibit  methemoglobin formation and  that  shaking in  itself  did not 
change oxyhemoglobin to methemoglobin.  While complete inhibition 
of methemoglobin formation took place in the unshaken tube in the 
presence  of homologous antipneumococcus serum,  in  the  tube  that 
was  shaken  so  that  the agglutinated clumps of bacteria were  more' 
or less  broken up  and  diffused throughout the  medium no inhibition 
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Further  experiments illustrating  this  point  were made  with  two 
strains of Streptococcus  viridans which, like the pneumococcus, trans- 
forms  oxyhemoglobin to  methemoglobin.  Strain  1  normally  grew 
diffusely in  serum-free bouillon,  but like many streptococci grew in 
granular clumps at the bottom of the culture tube in the presence of 
serum.  By  growing  this  streptococcus  in  tubes  containing  anti- 
pneumococcus serum,  it  was  possible  to  inhibit  completely for  24 
hours  the  formation  of  methemoglobin  as  shown  in  Table  VIII, 
demonstrable  methemoglohin  being  present  only  after  gradual 
diffusion of the medium took place. 
TABLE  VIII. 
Inhibition of Methemoglobin Formation by Streptococcus viridans by Antipneumo- 
coccus Serum. 
Methemoglobin  Hemoglobin solution  1 cc. q-  formation. 
Character of 
growth. 
Culture  0.00001  cc.  Serum  icc. 
Streptococcus viridans  1 
"  "  1 
Antipneumococcus  Serum 
Type I 
Antipneumococcus  Serum 
Type II 
Normal horse serum. 
Bouillon 1 cc. 
After  After 
24 hrs.  48 hrs. 
-  + 
-  + 
+  ++ 
++  ++ 
Sediment. 
~c 
and  dif- 
fuse. 
Diffuse. 
This  inhibition  cannot  be  attributed  to  any  specific  immunity 
principle in  the serum and is more probably brought about by the 
growth of  the  streptococci at  the bottom  of the  culture  tube  and 
their consequent inability to act on the medium as a whole. 
Streptococcus  viridans  2  normally grew as  a  sediment in  bouillon 
and  produced  methemoglobin slowly  as  the  growth  gradually  ex- 
tended up  the sides of the tube  and diffusion of the medium took 
place.  By shaking a  culture of Streptococcus  viridans  2 so that  the 
organisms were in continual intimate contact with the whole medium 
it was found that the transformation of oxyhemoglobin to methemo- 
globin took place rapidly and was complete by the end of 6  hours, :FRANCIS  G.  BLAKE  573 
at which time the unshaken control tubes failed to show any trace of 
methemoglobin (Table IX). 
TABLE  IX. 
Effect  of Shaking on Methemoglobin Formation  by Streptococcus viridans. 
Materials used. 
Streptococcusviridans  2, 0.5 cc. +  hemoglobin solution 1 cc. +bouillon 1 cc. 
(shaken) ........................................................ 
Stmptococcusviridans  2, 0.S cc. +hernoglobin  solution 1 cc. +bouillon 1 cc. 
(unshaken) ...................................................... 
Hemoglobin solution 1 cc,  +  bouillon 1.5 cc.  (shaken) ................. 
"  "  1  "  +  "  1.5  "  (unshaken) ............... 
Methemoglobiu 
formation  after 
incubation at 
37°C 
3 hrs.  6 hrs. 
--  ++ 
It  is  evident from  this  experiment that  the  rapid  formation of 
methemoglobin by this  streptococcus depended upon its  ability to 
grow in intimate contact with the whole medium. 
Comparison of the inhibitory power of immune serum in parallel 
series  of test-tube cultures and flask cultures confirmed the results 
of  the  shaking experiments.  It  was found that  while marked re- 
tardation of metabolic function as measured by~ the  change in the 
medium occurred in  the  test-tube  in  the  presence  of  homologous 
immune serum, no inhibition occurred in the flask cultures in which 
the  agglutinated bacteria were able  to  come into intimate contact 
with the medium as a  whole.  This is clearly shown in the experi- 
ments recorded in Table X. 
From these experiments it is evident that antipneumococcus serum 
exerted no inhibitory action on the fermentation of litmus milk or 
on the splitting of protein by the pneumococcus when the organisms 
were grown in flask cultures, in striking contrast with the results in 
the test-tube cultures.  Identical results were obtained with respect 
to the fermentation of inulin. 
These two groups of experiments seem to throw considerable doubt 
on the theory that antipneumococcus serum possesses  the property 
of inhibiting the metabolic activities of the pneumococcus by virtue 
of  a  specific  antiblastic  immunity principle.  They rather indicate 574  ANTIBLASTIC  IMMUNITY 
TABLE  X. 
Relation of the Inhibition of the Metabolic Activities of the Pneumocoecus by Anti- 
pneumococcus Serum to the A 3ility of the Pneumococeus to Act on the Medium 
as a Whole. 
Fermentation of Litmus Milk. 
Litmus milk 4 co. + 
Culture 0.000001 cc.  Serum i  cc. 
Pneumoco,  ccus Type II 
"  "  II 
"  "  II 
Antipneumococcus  Serum 
Type I 
Anfipneumococcus  Serum 
Type II 
Normal horse serum. 
Test-tube 
cultures.  Flask cultures. 
,: 
i+++  ÷÷ 
±  ++  ++  ++ 
++ ++  ++ ++ +-t  ++ 
Digestion of Protein. 
Broth 8 cc. + 
Culture 0.000002 cc. 
Pneumococcus Type I 
¢~  *¢  I 
Serum 2 cc. 
Antipneumococcus Serum Type  I 
"  "  "  II 
Normal horse serum. 
Increase [n  am- 
ino nitrogen per 
ce. after 48 hrs. 
at 37°C. 
Test-  I  Flask 
ibecul-  eul- 
Lures.  tures. 
rag"  I  rag. 
0.031  0.169 
0.103  0.120 
0.106  0.154 
that  the  inhibition  which  occurs  under  certain  experimental  con- 
ditions is in reality due to agglutination  of the pneumococci by the 
immune serum and their consequent inability to come into intimate 
contact with the medium as a  whole. 
Inhibition of the Metabolic Activities of Staphylococcus pyogenes  aureus 
by Antistaphylococcus Serumt 
Characteristic  metabolic  functions  of  Staphylococcus  pyogenes 
aureus  are the liquefaction of gelatin,  the formation of a  golden pig- 
ment,  and  the  transformation  of  oxyhemoglobin  to  a  magenta- 
colored unstable  compound, which is  probably reduced  hemoglobin. FRANCIS  G.  BLAKE  575 
A  limited  series of experiments  has been carried out to determine  the 
ability  of antistaphylococcus  serum  to inhibit  or retard  these  meta- 
bolic  activities  of  Staphylococcus  pyogenes  aureus.  The  staphylo- 
coccus used in  the  experiments  was  obtained  by blood culture  from 
a  case  of  staphylococcus  septicemia  and  an  autologous  immune 
serum was prepared by the immunization of a rabbit with this staphy- 
lococcus. 
Experiment  9.  Inhibition  of  the  Liquefaction  of  Gelatin by  Antistaphylo- 
coccus Serum.--The  liquefaction of gelatin is a characteristic metabolic function 
of  Staphylococcus pyogenes aureus.  In  a  series  of  experiments to determine 
the inhibitory action  exerted  by antistaphyloeoccus serum on this  activity  of 
the  staphylococcus  it  was  found  that  complete inhibition  occurred.  One  of 
these experiments is shown in Table XL  Incubation of the  culture  tubes  was 
carried out at 20°C, so that no agglutination of the staphylococci would occur. 
It should  be noted that in the tube containing antistaphylococcus serum there 
was  no  apparent  inhibition  of  growth of the staphylococci as compared with 
that  in the control tube.  In other words, although the liquefaction of gelatin 
was  completely inhibited,  the immune  serum exerted no apparent antagonistic 
action towards those metabolic activities  of the staphylococcus which are essen- 
tim to its growth and multiplication. 
TABLE  XI. 
Inhibition  of the Liquefaction of Gelatin by Antistaphylococcus Serum. 
Gelatin 4 cc. + 
Culture 0.000001 cc. 
Staphylococcus pyogenes aureus. 
Serum 1 cc. 
Anfistaphylococcus serum. 
Normal rabbit serum. 
Liquefaction of 
gelatin 
after  incubation 
at  20°C. 
--T  ~  9 
days. days. days. 
+%+-++-÷ 
Experiment 10.  Inhibition of Pigment Formation by Antistaphylococcus Serum.- 
When staphylococci were grown on the surface of serum agar slants and in serum 
agar  shake  cultures,  it  was  found  that  antistaphylococcus  serum  exerted  no 
inhibitory effect on pigment formation by the organisms.  It was felt that under 
these conditions the serum might not be in sufficient concentration in the immedi- 
ate  vicinity  of  the  staphylococcus colonies  to  exhibit  any  demonstrable  anti- 
blastic action.  In order to obviate this objection as far as possible,  serum agar 
plates were prepared (serum 1 part to plain agar 4 parts) and a thin layer of serum 
was spread over the surface of the agar which was then streaked with a loop of 576  ANTIBLASTIC LM~UNITY 
staphylococcus  culture.  The plates were sealed  to prevent evaporation of the 
serum as far as possible and incubated at room temperature.  Under these con- 
ditions the growing staphylococcus  colonies were in  intimate  contact  with  the 
serum.  It  was  found  that  antistaphylococcus serum  defirdtely  retarded  the 
formation of pigment by Staphylococcus pyogenes aureus  (Table XII),  although 
it exerted no apparent inhibitory action on the rate of growth of the bacteria, as 
compared with the growth in the presence of normal serum. 
TABLE  XlI. 
Inhibition of Pigment Formation by Antistaphylococcus Serum. 
Materials used. 
Antistaphylococcus  serum agar  +  Staphylococcus pyogenes 
aureus  .................................................... 
Normal serum agar +  Staphylococcus pyogenes aureus  ............ 
Pigment formation. 
After  I  After  ]  After 
[  +  I++ 
This inhibition of pigment formation by antistaphylococcus serum 
must be attributed to some definite antagonistic property of the serum 
toward  this  function  of the  staphylococcus.  It  should  not  be  con- 
cluded,  however,  from  this  inhibitory phenomenon that the  antag- 
onistic  action  of  the  serum  is  definitely  antienzymotic  in  nature, 
for  it  is  not  definitely known  that  pigment  formation  by  Staphy- 
lococcus pyogenes  aureus is  caused by enzyme action.  Certainly the 
formation of pigment  is  not essential  to  the  life and  growth  of the 
staphylococcus, for it does not occur during the early stages of growth 
and appears only after the staphylococcus colonies are well developed 
and  multiplication  probably  has  in  large  measure  ceased.  Further 
experiments  are  necessary  to  establish  the  exact  nature  of  this  in- 
hibitory action of antistaphylococcus serum. 
Experiment 11.  Inhibition  of the Reduction  of Oxyhemoglobin by Antistaphylo- 
coccus Serum.--To  determine the  inhibitory effect  of antistaphylococcus serum 
on the reduction of oxyhemoglobin by Staphylococcus pyogenes aureus, two series 
of experiments were made, one with the use of a 5 per cent suspension of washed 
rabbit corpuscles, the other with a solution of hemoglobin prepared from rabbit 
corpuscles as in the pneumococcus experiments.  A typical experiment is shown 
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TABLE  XIII. 
Inhibition of the  Reduction of OxykemogloMn by  Antlstapkylococcus Serum. 
Suspension  of rabbit corpuscles I  cc. + 
Culture 0.000001 cc. 
Stapkylococcus  pyogenes  aureus. 
gc  g~  ~g 
Serum 0.5 cc. 
Antistaphylococcus serum. 
Normal rabbit  " 
Reduction of 
oxyhemoglobin 
after  incubation 
at 37"C. 
24 hrs. ] 43 hrs. 
+_+ 
Hemoglobin  solution  1 cc. "t'- 
Culture  0.000001 cc. 
Staphylococcus  pyogenes aureus. 
Serum 0.5 cc, 
Antistaphylococcus  serum. 
Normal rabbit  " 
Reduction of 
or]hemoglobin 
after  incubation 
at 37°C. 
24 hrs. 1 48 hrs. 
++ 
It was found that the reduction of oxyhemoglobin was not inhibited 
by antistaphylococcus  serum when rabbit  corpuscles were used, but 
that inhibition occurred when a hemoglobin solution was substituted 
for the corpuscle suspension.  This difference is readily explained on 
the  basis of  the  results  obtained in  the  pneumococcus experiments. 
In  the  tubes  containing  rabbit  corpuscles  the  blood  cells  rapidly 
settled to the bottom of the tube where they were in intimate contact 
with the agglutinated staphylococci,  and were therefore in a position 
to be acted upon by the organisms.  In the tubes containing hemo- 
globin solution, however, the agglutinated staphylococci were not in 
intimate  contact  with  the  hemoglobin  held  in  solution  throughout 
the medium and consequently were unable to act upon it within the 
time  limits  of  the  experiment.  When  the  agglutinated  clumps  of 
staphylococci were broken up and dispersed throughout the medium 
by  shaking,  the  hemoglobin  solution  was  rapidly  reduced.  From 
these experiments it is evident  that  antistaphylococcus  serum  pos- 
sesses no specific antiblastic property which enables it to inhibit the 
reduction of oxyhemoglobin by Staphylococcus  pyogenes aureus. 578  ANTIBLASTIC  IMMUNITY 
DISCUSSION. 
The series of experiments reported in this paper were undertaken 
in an attempt to explain the mechanism by which immune serum is 
able  to  retard or inhibit  the metabolic activities of bacteria.  This 
property of immune serum has been attributed by previous investi- 
gators to an antienzymotic or antiblastic action of the serum which 
exerts itself at the point of contact of the bacterial cell with its environ- 
ment.  While it has been clearly demonstrated in confirmation of the 
work of other observers that  under certain experimental conditions 
immune serum does exert an apparent inhibitory action  on  the  nu- 
tritional and certain other metabolic processes of bacteria, the facts 
brought out as the experiments progressed have made it seem prob- 
able that the inhibitory action exerted by antipneumococcus serum 
is not due to a  specific antienzymotic or antiblastic property of the 
serum, but rather to its  agglutinating properties.  It is well recog- 
nized that many bacteria grow readily in homologous immune serum, 
provided the serum does not possess definite bactericidal properties, 
a fact which in itself would tend to throw some doubt on the validity 
of  the  antiblastic  theory  as  applicable  to  all  immune  sera,  since 
metabolic activity is considered to be essential to bacterial nutrition 
and growth.  Bacteria when cultivated in media containing immune 
serum grow in agglutinated clumps at the bottom of the culture tube. 
Under these conditions they do not come into intimate contact with 
the whole medium and  are unable  to  bring  about  changes rapidly 
throughout the medium.  Presumably the metabolic activities which 
bacteria carry on in the process of growth exert their influence on the 
medium only in the immediate vicinity of the agglutinated organisms 
during the early stages of growth, and only as gradual diffusion of the 
medium takes place are the bacteria able to act upon the whole me- 
dium in sufficient degree to bring about those changes which indicate 
that bacterial metabolism is taking place.  That these considerations 
hold with respect to the influence exerted by antipneumococcus serum 
on  the metabolic  activities of the pneumococcus has  been  demon- 
strated in the experiments reported above, in which it has been shown 
that  the metabolic activities of the pneumococcus do  take place in 
the immediate vicinity of the agglutinated bacteria in  spite  of the r~_NClS  G.  BLAI<E  579 
presence of immune serum;  that  the  degree of apparent  inhibition 
which antipneumococcus serum exerts upon the metabolic activities 
of the pneumococcus depends upon the extent of agglutination of the 
organisms; that antipneumococcus serum exhausted of its agglutinin 
content possesses  no  antiblastic  properties;  that  antipneumococcus 
serum possesses the property of apparently inhibiting the metabolic 
activities  of  entirely  unrelated  bacteria  provided  those  bacteria 
grow in sedimented clumps in  the presence of the serum; and that 
when pneumococci are grown in  the presence of antipneumococcus 
serum under conditions that enable them to come into intimate con- 
tact  with  the  whole  medium,  no  inhibition  of  metabolic  activity 
takes place. 
A  limited number of experiments with  antistaphylococcus serum 
has  confirmed  the  results  obtained  with  antipneumococcus serum 
in  as far as the inhibitory effect of the serum on  the reduction of 
oxyhemoglobin by the staphylococcus is  concerned.  On  the other 
hand, antistaphylococcus serum has been found to inhibit or markedly 
retard  the formation of pigment and the liquefaction of gelatin by 
Staphylococcus  pyogenes aureus.  Under the conditions of the experi- 
ments agglutination of the bacteria did not occur and therefore could 
not have been a  factor in causing the inhibition.  It is to be noted 
that neither pigment formation nor the liquefaction of gelatin is an 
essential process in the nutrition of the staphylococcus and that these 
phenomena take place in demonstrable amount only after the staphy- 
lococcus colonies have become well developed.  It is felt that further 
experimental work is  necessary to  determine the  exact mechanism 
of the inhibitory action of antistaphylococcus serum on these functions 
of the staphylococcus before the conclusion can be safely drawn that 
it is of an antienzymotic nature.  The outstanding fact that staphy- 
lococci as well as pneumococci grow rapidly and abundantly in the 
homologous immune serum is sufficient in itself to indicate that the 
immune  serum  possesses  no  properties  in  demonstrable  amount 
antagonistic  to  those bacterial  metabolic activities  essential  to  the 
growth and multiplication of the bacteria. 580  ANTIBLASTIC  IMMUNITY 
CONCLUSIONS. 
Antipneumococcus  serum  under  certain  conditions  apparently 
inhibits or retards the metabolic activities of the homologous pneu- 
m0COCCUS. 
Antipneumococcus  serum  exhausted  of  its  agglutlnin  content 
possesses no inhibitory properties. 
The degree of inhibitory action of antipneumococcus serum parallels 
its agglutinating power. 
No evidence has been found to indicate that the inhibition of the 
metabolic activities of the pneumococcus by antipneumococcus serum 
is due to a specific antienzymotic property of the serum. 
The evidence which has been obtained indicates that the apparent 
inhibition of metabolic activity that occurs under certain conditions 
is due to agglutination of the pneumococci by the antipneumococcus 
serum  and  their  consequent inability  to  grow in  intimate contact 
with the whole medium. 
Antistaphylococcus serum inhibits the liquefaction of gelatin and 
the formation of pigment by Staphylococcus  pyogenes aureus.  Further 
experimentation is  necessary  to  determine  the  mechanism of  this 
inhibitory action. 
Antistaphylococcus serum does not inhibit those metabolic activi- 
ties  of Staphylococcus  pyogenes  aureus  essential  to  the growth and 
multiplication of the orggnisms. 